Heat therapy via endoscope tested for abdominal tumors

NCT ID NCT03221335

Recruiting now Disease control Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a procedure called EUS-guided radiofrequency ablation (RFA) for solid tumors in the stomach, liver, kidney, or adrenal glands. It involves using an endoscope to insert a needle that heats and destroys tumor tissue. The study will enroll 30 adults who cannot have surgery, to see if the procedure is safe and works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiofrequency ablation (RFA) delivered via endoscope
What this could lead to: If successful, this could offer a less invasive treatment option for people with solid abdominal tumors who cannot have surgery.
What could go wrong: This is a small early study (30 people) focused on safety. The procedure may cause side effects like pancreatitis or thermal injury, and it is not yet proven to be effective long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIGESTIVE SYSTEM NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adrenal gland neoplasm digestive system neoplasm Digestive System Neoplasms gastric neoplasm kidney neoplasm liver and intrahepatic bile duct neoplasm renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIGESTIVE SYSTEM NEOPLASMS

Contacts and locations

Locations

Department of Surgery, Prince of Wales Hospital
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.